1. First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers

   Komdeur, F. L., Singh, A., van de Wall, S., Meulenberg, J. J. M., Boerma, A., Hoogeboom, B. N., Paijens, S. T., Oyarce, C., de Bruyn, M., Schuuring, E., Regts, J., Marra, R., Werner, N., Sluis, J., van der Zee, A. G. J., Wilschut, J. C., Allersma, D. P., van Zanten, C. J., Kosterink, J. G. W., Jorritsma-Smit, A., Yigit, R., Nijman, H. W. & Daemen, T., 2020, (Accepted/In press) In : Molecular Therapy.

   Research output: Contribution to journal › Article › Academic › peer-review

2. (Pre)maligniteit van de cervix behandelen met therapeutische vaccinatie

   Komdeur, F., Van De Wall, S., Singh, A., Yigit, R., Nijman, H. & Daemen, T., 2018, In : Nederlands Tijdschrift voor Obstetrie en Gynaecologie. 131, april 2018, p. 129-132 4 p.

   Research output: Contribution to journal › Article › Professional

3. PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

   van den Heerik, A. S. V. M., Horeweg, N., Nout, R. A., Lutgens, L. C. H. W., van der Steen-Banasik, E. M., Westerveld, G. H., van den Berg, H. A., Slot, A., Koppe, F. L. A., Kommoss, S., Mens, J. W. M., Nowee, M. E., Bijmolt, S., Cibula, D., Stam, T. C., Jurgenliemk-Schulz, I. M., Snyers, A., Hamann, M., Zwanenburg, A. G., Coen, V. L. M. A., Vandecasteele, K., Gillham, C., Chargari, C., Verhoeven-Adema, K. W., Putter, H., van den Hout, W. B., Wortman, B. G., Nijman, H. W., Bosse, T. & Creutzberg, C. L., 2020, In : International Journal of Gynecological Cancer. 6 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. PROGNOSTIC INTEGRATED IMAGE-BASED IMMUNE AND MOLECULAR PROFILING IN EARLY-STAGE ENDOMETRIAL CANCER

   Horeweg, N., de Bruyn, M., Nout, R. A., Stelloo, E., Kedzierska, K. Z., León-Castillo, A., Plat, A., Mertz, K. D., Osse, M., Jürgenliemk-Schulz, I. M., Lutgens, L. C., Jobsen, J. J., van der Steen-Banasik, E. M., Smit, V. T. H. B. M., Creutzberg, C. L., Bosse, T., Nijman, H. W., Koelzer, V. H. & Church, D. N., 30-Sep-2020, In : Cancer immunology research. 13 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Association of Homozygous Variants of STING1 with Outcome in Human Cervical Cancer

   Lubbers, J. M., Koopman, B., de Klerk-Sluis, J. M., van Rooij, N., Plat, A., Pijper, H., Koopman, T., van Hemel, B. M., Hollema, H., Wisman, B., Nijman, H. W. & de Bruyn, M., 10-Oct-2020, In : Cancer science.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (178) »

1. Interview bij ZonMW

   Hans Nijman

   20/09/2019

   1 Media contribution

   Press/Media: Public Engagement Activities › Professional

2. Immunoncologie artikel therapeutisch HPV vaccin voor cervixcarcinoom

   Hans Nijman

   25/08/2019

   1 item of Media coverage

   Press/Media: Research › Professional

3. Kankervaccin klaar voor tests op patiënten

   Toos Daemen & Hans Nijman

   18/04/2016

   1 item of Media coverage

   Press/Media: Research › Popular

View all (3) »

1. Gynaecongres

   Hans Nijman (Invited speaker)

   17-May-2019

   Activity: Participating in or organising an event › Participation in conference › Professional

2. Olijf congresdag 2019

   Hans Nijman (Invited speaker)

   28-Sep-2019

   Activity: Participating in or organising an event › Participation in conference › Academic

3. Refereeravond vulvapathologie

   Hans Nijman (Consultant)

   23-Jan-2019

   Activity: Consultancy › Professional

View all (48) »